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ABSTRACT
Adrenomedullin (AM) is a recently identified
amidated peptide produced by a variety of tissue
types. We have investigated the involvement of AM
and its receptor (AM-R) in developing mouse
mammary glands and have examined what influence
ovarian hormones have on AM and AM-R
expression in this system. Tissues from ductal
morphogenesis, virgin adult, pregnancy, and lacta-
tion stages were assessed for AM and AM-R by
molecular, biochemical and immunohistochemical
techniques. Results from these studies indicated
that messenger RNA for AM and AM-R and
immunoreactivity for AM were expressed in the
luminal epithelium of small and large ducts and in
terminal end buds. Immunoreactive AM was
identified as a cytoplasm component of ductal cells,
with some cells also having nuclear staining.
Western blot analysis of mammary gland tissues
yielded two molecular mass species (Mr 14 000 and
18 500) of AM immunoreactivity in the mammary
gland for the above developmental stages, consistent
with processed intermediate and prohormone forms
respectively. Ovariectomy alone or followed by
hormonal treatments did not alter the expression
pattern for these two proteins. By Western blot, the
fully processed AM form (Mr 6000) was identified
in milk extracts from lactating glands. These data
suggest a potential role for AM and its receptor in
the maintenance of mammary gland homeostasis
and suggests a potential role for AM in development
of the newborn.
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INTRODUCTION
Adrenomedullin (AM) is a potent hypotensive 52
amino acid peptide originally isolated from human
pheochromocytoma (Kitamura et al. 1993a). It is
synthesized as a 185 amino acid precursor which is
processed by consecutive enzymatic steps into a
6000 molecular mass bioactive peptide (Kitamura
et al. 1993b, Sugo et al. 1994). AM production has
been characterized in a wide spectrum of tissues,
including the cardiovascular (Sakata et al. 1993),
nervous (Ueta et al. 1995, Wang et al. 1995, Satoh
et al. 1996), respiratory (Martı´nez et al. 1995b),
endocrine (Martı´nez et al. 1996, Satoh et al. 1996),
renal (Jougaski et al. 1994), and digestive systems
(Washimine et al. 1995). AM mRNA expression is
enhanced by inflammatory response elements
(interleukin-1 and tumor necrosis factor) and the
peptide is markedly up-regulated in the circulation
following endotoxin (lipopolysaccharide) challenge
or bacterial sepsis (Sugo et al. 1995, Hirata et al.
1996). A variety of biological eVects have been
assigned to AM which include: vasodilator
(Kitamura et al. 1993a, Eguchi et al. 1994, Lippton
et al. 1994, Nossaman et al. 1995), bronchodilator
(Kanazawa et al. 1994), neurotransmitter (Allen &
Ferguson 1996), anti-secretagogue (Samson et al.
1995, Yamaguchi et al. 1995, Martı´nez et al. 1996),
and a promoter of cell proliferation (Miller et al.
1996, Withers et al. 1996). AM has been shown to
mediate these bioactive eVects through a seven-
transmembrane G-protein associated receptor
which acts through the activation of adenyl cyclase
(Ishizaka et al. 1994, Kapas et al. 1995).
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In the mammary gland from nulliparous mice,
growth and maintenance of ductal epithelium is
primarily dependent upon the ovarian steroids,
estrogen and progesterone; following conception,
ductal branching, alveolarization and lactation allow
for terminal diVerentiation of the gland (Nandi
1958). Several of these mammary gland processes
have been shown to be modulated by cAMP levels
(Rillema 1976, Silberstein et al. 1984). In light of
previous reports suggesting a role for AM in
hormone secretion, cell growth and cAMP regula-
tion, we investigated the involvement of AM and its
receptor (AM-R) in the mouse mammary gland. In
addition, we examined whether this ligand/receptor
relationship was influenced in a hormone-dependent
and developmentally-specific manner. Both molecu-
lar and biochemical studies were performed on the
mammary glands of mice at various stages of
development: peripubertal and mature virgin mice
and pregnant and lactating adult mice. Additionally,
we evaluated ovariectomized adult virgin mice for
AM and AM-R expression before and after estrogen
and/or progesterone treatment.
MATERIALS AND METHODS
Animals
Female mice (CD-1 (Crl:CD-1(ICR)), Charles
River Breeding Laboratories, Raleigh, NC, USA)
were housed under controlled temperature (22 )C),
with a ratio of 12 h light:12 h darkness and humidity
(50%), and were given NIH31 rodent diet and
water and allowed to feed ad libitum. All animal
experimental protocols were approved by the
NIEHS Animal Care and Use Committee. Animals
were anesthetized with ketamine/xylazine and
killed by cervical dislocation. For RNA or protein
extraction, tissues were rapidly removed under
aseptic conditions, frozen in liquid N2 and then
stored at "80 )C. Lymph nodes were dissected
from the mammary tissue before further tissue
extraction.
Hormone treatments
Female virgin mice were ovariectomized by the
breeder at maturity (8 weeks) and then housed at
NIEHS. At 20 weeks of age, animals were divided
into four treatment groups of six each and received
a daily injection (0·1% body weight, s.c.) of corn
oil (control group), 17-â estradiol (1 µg/day),
progesterone (1 mg/day) or a mixture of both
estradiol (1 µg/day) and progesterone (1 mg/day)
for a period of 7 days before killing on day 8
(Haslam et al. 1992). Estradiol and progesterone
were obtained from Sigma Chemical Company
(St Louis, MO, USA). The tissues obtained for
paraYn embedding were fixed in 10% neutral
buVered formalin for 18–24 h. Whole mounts of
mammary gland tissue were prepared as previously
described (Russo et al. 1989).
Cell culture and RNA extraction
NIH-H720, a lung carcinoid cell line, was used as a
positive control (NCI-Navy Oncology Medical
Branch). Cells were grown in serum-free, hormone-
free medium as previously described (Martı´nez
et al. 1995a). mRNA was extracted from fresh
cell pellets using the Trizol reagent (Life Tech-
nologies, Gaithersburg, MD, USA) following the
manufacturer’s procedure.
Frozen tissues were homogenized with a Polytron
homogenizer (setting 8, 30 s) in TriReagent
(Millipore, Bedford, MA, USA) following the
manufacturer’s instructions. The amount of RNA
isolated was determined spectrophotometrically.
RT-PCR and Southern blot analysis
Poly A+ mRNA from normal human lung was
purchased from Clontech (Palo Alto, CA, USA).
Reverse transcription polymerase chain reaction
(RT-PCR), and Southern blot were carried out as
previously described (Martı´nez et al. 1996). A set
of primers that recognizes the most conserved
regions of the AM gene was designed and is shown
in Table 1. â-2 microglobin, a protein component of
the cell membrane, was used to verify the presence
of RNA in the RT-PCR samples (data not shown).
PCR for AM and â-2 microglobin was performed
at 94 )C for 15 s, 55 )C for 15 s, 72 )C for 1 min for
35 cycles. The same PCR conditions were used for
AM-R except that the annealing temperature was
61 )C. All RT-PCR primers and the probes are
listed in Table 1.
One percent agarose gels were run at 100 V for
approximately 2·5 h, then denatured in 1·5 m
NaCl/0·6 m NaOH (2#30 min) and 1·5 m NaCl/
2 m Tris (2#30 min) and blotted overnight onto a
0·2 mm nitrocellulose filter in 20#SSC by capillary
flow transfer. The filter was cross-linked at 80 )C
under vacuum and incubated in hybridization
buVer. The antisense nested probes for AM or
AM-R were 32P-endlabeled by standard procedures
and hybridization with the probe was carried out
overnight at 42 )C. Room temperature stringency
washing was in 5#SSC/0·1% SDS and 1#SSC/
0·1% SDS. Filters were air dried and autoradio-
graphed on Kodak XAR5 film.
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Western blotting
Whole cell lysates of tumor cell line NIH-H720
were generated following a slightly modified
protocol from that previously reported (Martı´nez
et al. 1995b). In summary, cells were harvested 48 h
after their last feeding, washed three times in cold
PBS and pelleted by centrifugation (1000 r.p.m. for
10 min at 4 )C). The pellet (5#107 cells) was
re-suspended in 1 ml cold PBS containing 1 mm
final concentration of each of the following protease
inhibitors: pefabloc (Centerchem Inc., Stanford,
CT, USA), bestatin and phosphoramidon (Sigma
Chemical Company). The cell suspension was
maintained at 4 )C at all times, then homogenized,
sonicated, clarified by ultracentrifugation and the
final protein concentration determined (BioRad
Laboratories, Richmond, CA, USA). Normal tissue
extracts were obtained from Clontech. BALB/c
mouse milk was acid-extracted with 2 N glacial
acetic acid and boiled for 10 min, followed by
centrifugation and collection of the supernatant.
Protease inhibitors (see above) were added to the
supernatant.
Cell lysates and tissue extracts (35 mg protein/
well) were electrophoretically fractionated on a 10–
20% Tricine gel (Novex, San Diego, CA, USA) at
100 V for 2 h under reducing (â-mercaptoethanol)
and non-reducing conditions. A total of 2 ng
synthetic AM (Phoenix Biochemicals, Phoenix, AZ,
USA) were added to a separate well as a positive
control standard. Transfer blotting was accom-
plished in the same apparatus equipped with a
titanium plate electrode insert and proteins aYxed
to a polyvinyldifluoride membrane (Immobilon
PVDF, Millipore) at 30 V for 2 h. Membrane was
blocked overnight in 1% BSA–PBS, incubated for
1 h in 1:1000 dilution of rabbit anti-P072 (bleed
#2343), washed 3#in PBS, exposed to 1#106
c.p.m. 125I-Protein A for 1 h at 28 )C, washed 6#
in PBS, dried and autoradiographed overnight at
"80 )C on Kodak XAR5 film. Specificity control
consisted of a duplicate membrane incubated in
diluted antiserum which had been preabsorbed with
10 nmol P072 antigen (Martı´nez et al. 1995b) per ml
diluted antiserum.
In situ RT-PCR
In order to determine tissue expression sites for
AM, a direct method for in situ amplification of
mRNA (Martı´nez et al. 1995a) was performed in a
Hybaid OmniSlide System thermocycler (National
Labnet Company, Woodbridge, NJ, USA). After
dewaxing, the sections were subjected to per-
meabilization with 10 mg/ml proteinase K (Sigma
Chemical Company) for 15 min at 37 )C. RT was
performed using the SuperScript Preamplification
System (Gibco BRL, Gaithersburg, MD, USA)
prior to the PCR. The Taq polymerase was blocked
with a specific monoclonal antibody (TaqStart,
Clontech) before being added to the PCR mixture
in order to obtain a synchronous ‘hot start’ for all
the slides. The PCR mixture contained 2·5 mm
MgCl2, 200 mm dNTPs, 100 mm digoxigenin-dUTP
(Boehringer Mannheim, Indianapolis, IN, USA),
1 ng of each primer, 50 mm KCl, 10 mm Tris–HCl,
pH 8·3. Products were located after PCR amplifica-
tion for 20 cycles (annealing temperature, 55 )C)
using a Digoxigenin Detection Kit (Boehringer
Mannheim, following manufacturer’s instructions).
Negative amplification controls included the omis-
sion of reverse transcriptase and the substitution of
the primers by water in the PCR mixture.
In situ hybridization
Detection of the AM-R mRNA was performed
using in situ hybridization as previously described
table 1. Sequences of the oligonucleotides synthesized for this study
Adrenomedullin (293 bp)
Sense (250–270) 5*-AAG-AAG-TGG-AAT-AAG-TGG-GCT-3*
Antisense (523–542) 5*-TGT-GAA-CTG-GTA-GAT-CTG-GT-3*
Probe (430–450) 5*-TCT-GGC-GGT-AGC-GCT-TGA-CTC-3*
Adrenomedullin receptor (471 bp)
Sense (476–497) 5*-AGC-GCC-ACC-AGC-ACC-GAA-TAC-G-3*
Antisense (923–946) 5*-AGA-GGA-TGG-GGT-TGG-CGA-CAC-AGT-3*
Probe (788–811) 5*-GGT-AGG-GCA-GCC-AGC-AGA-TGA-CAA-3*
â2 Microglobulina (217 bp)
Sense (235–256) 5*-GAC-TGG-TCT-TTC-TAT-ATC-CTG-G-3*
Antisense (432–452) 5*-CTT-TCT-GCG-TGC-ATA-AAT-TG-3*
aPrimer sequences courtesy of F Flomerfelt, National Institutes of Health.
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(Martı´nez et al. 1996). The full-length cDNA was
ligated into the expression vector pcDNA1 (Kapas
et al. 1995) and used to generate riboprobes. The
plasmid was linearized with EcoRV and BamHI and
was used as a template to synthesize digoxigenin-
labeled sense and anti-sense RNA transcripts.
Hybridization was performed in a moist chamber at
46 )C for 20 h in a 20 ml volume containing 2·5 ng
probe/ml. After stringency washes, visualization of
digoxigenin was performed using a detection kit
(Boehringer Mannheim). Controls included the use
of the sense probe and digestion with RNase before
hybridization.
Immunohistochemistry
An avidin–biotin–peroxidase complex method was
performed in paraYn sections as previously re-
ported (Martı´nez et al. 1995b, 1996), except that
phosphate-buVered saline was replaced with 50 mm
Tris, 0·1% bovine serum albumin, 0·9% NaCl. The
polyclonal antibody specific to AM was used for
immunohistochemistry at a concentration 1:1000.
Negative controls included substitution of the
primary antibody by pre-immune serum from
the same rabbit and solid phase preabsorption of
the antibody overnight at 4 )C with 10 nmol/ml
synthetic peptide.
RESULTS
AM and AM-R expression in mouse
mammary tissue extracts
The presence of mRNA for AM and AM-R was
determined by RT-PCR in mouse mammary glands
at diVerent developmental stages and after estradiol
or progesterone treatment of virgin, ovariectomized
mice. Oligonucleotide probes specific to AM or
AM-R cDNA (Table 1) were hybridized to Southern
transferred amplified products (Fig. 1A and B). All
samples expressed AM and AM-R by either this
method or by ethidium bromide staining of the gel
purified amplified product (data not shown); the
control ovariectomized group expressed AM-R
RNA by the latter method. NIH-H720 human lung
carcinoid cell-line and rat lung tissue (Martı´nez
et al. 1995b) were used as positive controls. RT-
PCR of the samples with â-2 microglobin primers
was used to verify the presence of intact RNA (data
not shown).
Western blotting of mammary tissue extracts
using a previously characterized (Martı´nez et al.
1995b) AM antibody to the C-terminal region of
the protein (P072, amino acids 116–146) revealed
immunoreactive bands at Mr 18 500 and 14 000 for
all tissue extracts examined (Fig. 1C). The former
size is consistent with unprocessed AM precursor
and the latter size with an intermediate form. The
Mr 6000 form of AM was not evident in any of the
samples tested, but was present in the Western
blot of synthetic AM. No immunoreactive bands
were evident by Western blotting using antibody
preabsorbed with the synthetic P072 (Fig. 1D).
AM immunoreactivity and localization of
mRNA for AM and AM-R following hormone
treatments
Whole mounts of the ovariectomized mammary
gland after hormone treatments (Fig. 2A–D)
showed changes in duct size, branching and
terminal endbud formation. Estradiol or estradiol
plus progesterone treatments resulted in terminal
endbud formation within the gland; progesterone or
estradiol plus progesterone treatments resulted in
increased ductal branching and increased duct
diameter. AM and AM-R specific gene expression
was localized in mammary tissues by in situ
RT-PCR and in situ hybridization respectively. In
all treatment groups, including vehicle control, AM
(data not shown) and AM-R mRNAs (Fig. 2E–H)
were found in mammary epithelial cells: luminal
cells of ducts and alveoli, myoepithelial cells and
cells comprising the terminal endbud. Immunoreac-
tivity for AM (Fig. 2I–L) paralleled localization of
AM mRNA expression. Periductal fibroblasts were
apparently negative for AM mRNA and protein,
but positive for AM-R mRNA (AM protein,
Fig. 2I–L; AM-R mRNA, Fig. 2E–H).
Localization of AM and AM-R during
mammary gland development
Immunostaining for AM in the cells of the ductal
epithelium was observed not only in the cytoplasm
but, in a high proportion of cells, also in the nucleus
(Figs 2L and 3A). Cytoplasmic staining tended to
be concentrated in the apical region of the cell.
Positive staining of the nucleus and cytoplasm was
abrogated by preabsorption of the AM antibody
with synthetic AM (Fig. 3B). Luminal epithelial
cells and periductal and fat pad fibroblasts were
positive for AM-R mRNA by hybridization to the
AM-R antisense probe (Fig. 3C) and negative
by hybridization to the sense probe (Fig. 3D).
Consistent results were observed for AM and
AM-R mRNA and AM immunoreactivity in
31-day-old virgin, 15-month-old virgin, as well as
14-day pregnant and 4-day post weaning stages of
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figure 1. Southern blot for AM (A) and AM-R (B) of PCR-amplified cDNA
and corresponding Western blot for AM (C) in mammary gland tissues. AM
antibody preabsorbed with synthetic P072 peptide (D). NCI-H720: human
carcinoid cell line; rat lung; mouse mammary gland from 31-day-old virgin,
15-month-old virgin; day 14 of pregnancy and day 18 of lactation. Ovex: adult
virgin mice 3 months post ovariectomy treatment for 7 days with: Control=corn
oil; E2=17-â estradiol; P4=progesterone. Tissues were collected on day 8. d=day;
m=month; ovex=ovariectomized; Water=negative amplification control.
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development (Fig. 4A–D, not all data shown).
Periductal and fat pad fibroblasts were positive for
mRNA to AM-R (Fig. 4E), but were immunonega-
tive for AM. The most striking positive staining for
AM and AM-R was obtained during lactation (Fig.
3A–D); luminal cells and milk within the ducts were
positive for AM immunoreactivity.
Localization of mature AM in mouse milk
Since milk within the ducts was immunoreactive for
AM (Fig. 3A), Western blot detection of AM was
carried out on mouse milk (Fig. 5). Mouse milk
showed evidence of three AM forms: the fully
processed AM form (Mr 6000), an intermediate
figure 2. Distribution of AM and AM-R in mammary glands from hormone-treated mice, 3 months after
ovariectomy. Seven day treatment with corn oil (A, E, I), estradiol (B, F, J), progesterone (C, G, K), or estradiol +
progesterone (D, H, L). Toluidine blue stained whole mounts (A–D). Arrows in A–D indicate ductal and endbud
structures within the fat pad. In situ hybridization with AM-R antisense probe (E–H). Immunohistochemical
staining with AM polyclonal antibody (I–L). Note in L the presence of epithelial cells with either negative
(large arrow) or positive (small arrow) nuclear staining. Magnification: A–D, #16; E, G, H, J, L, #193;
F, I, K, #387.
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form (Mr 14 000), and unprocessed, prohormone
form (Mr 18 500). Under reducing conditions,
all bands were greater in intensity. No bands
were evident with antibody preabsorbed with the
synthetic P072 antigen (Fig. 5B).
DISCUSSION
Prior molecular studies on AM and AM-R have
demonstrated message expression in a variety of
tissues including the adrenal gland, heart, lung,
kidney (Kitamura et al. 1993a, Sugo et al. 1995,
Martı´nez et al. 1995b) and pancreas (Martı´nez et al.
1995b). Our identification of AM and AM-R in the
mouse mammary gland is another example of the
ubiquity of this peptide and its receptor. Evaluation
of ductal epithelium by in situ PCR showed AM
mRNA in the same cell type that stained a serial
section positive for the peptide by immunohisto-
chemistry. In situ hybridization analysis for AM-R
message also demonstrated epithelial expression of
the receptor, suggesting an autocrine pathway
within this cell type. Interestingly, periductal
fibroblasts were shown to have AM-R message, but
lacked AM, implying a paracrine mode of action
associated with their cellular physiology.
The presence of mRNA and immunoreactivity
for AM in epithelial cells, but not in the periductal
and fat pad fibroblasts, and the presence of mRNA
for AM-R in both cell populations suggests that
AM is involved in mesenchymal–epithelial inter-
actions within the mammary gland. Communication
of the mammary mesenchyme (periductal fibro-
blasts) with the epithelium is essential for mammary
growth and development from embryonic through
adult stages (reviewed in Cunha & Hom 1996).
Parallels of our findings have been seen for growth
factors such as transforming growth factor-á/
epidermal growth factor (EGF) receptor (Snedeker
et al. 1991) or keratinocyte growth factor (Cunha &
Hom 1996). Further investigations could utilize the
cleared mammary fat pad model and neutralizing
antibodies or peptide antagonists to AM or AM-R
figure 3. Immunohistochemical localization of AM and in situ hybridization for AM-R in the lactating mammary
gland. (A) Positive localization for AM at day 18 of lactation. (B) Staining of a serial tissue section with antibody to
AM preabsorbed with synthetic P072. (C) In situ hybridization for AM-R with the antisense probe. (D) Negative
control using AM-R sense probe in a serial tissue section. d=ductal lumen. Magnification: A–D, #239.
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to determine the role of these factors in the growth
and development of the mammary gland.
It has been previously shown by radioimmuno-
assay quantitation and immunohistochemical detec-
tion that AM is ubiquitously expressed in all
the major organs of several mammalian species
(Kitamura et al. 1993a, Sugo et al. 1995, Martı´nez
et al. 1995b, 1996). We have used a concomitant
approach of immunohistochemical and in situ
RT-PCR to localize AM expression in mouse
mammary glands. By Western blot analysis of the
immunoreactive tissue products, AM-like activity
was shown to be comprised of two molecular mass
species (18 500 and 14 000) in all developmental
stages examined. Three species were identified by
western analysis of acid-extracted mouse milk: Mr
18 500, 14 000, and 6000, the bioactive AM form.
However, Western analysis of the mammary tissue
at lactation stage did not yield an immunoreactive
band at 6000. Physiological reasons to be considered
for this apparent discrepancy are the rapid cleavage
and release of AM into lumenal fluid (Miller et al.
1996) and the heterogeneity of the mammary tissue.
Other investigators have reported similar discrepan-
cies in the study of EGF processing within the
mammary gland. Although EGF is found in milk,
they were unable to detect the mature peptide (Mr
6000) by standard Western blotting or immuno-
precipitation of radioactive protein (Brown et al.
1989) from mammary tissue.
Several studies have now shown that AM can
function as a growth regulator in both normal and
malignant cells (Chini et al. 1995, Kano et al. 1996,
Miller et al. 1996, Withers et al. 1996). In vitro
figure 4. In situ distribution of AM and AM-R in the virgin mouse mammary gland. In situ RT-PCR
(A) and immunohistochemistry (B) for AM in the terminal endbud from a 31-day-old mouse. In situ
hybridization for AM-R (C) and immunohistochemistry for AM (D) in a 15-month-old virgin mouse.
Positive staining for AM-R in fibroblasts from C (E). Magnification: A and B,#598; C,#134; D and
E,#260.
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assessment has demonstrated the ability of AM to
mediate either a proliferative or suppressive eVect
on growth, depending on the target cell examined
(Kano et al. 1996, Miller et al. 1996). Since AM is
an inducer of cAMP, its reputed diametric growth
eVects are thought to involve the cAMP-dependent
protein kinase A isoforms, RI and RII, which are
known to regulate cell proliferation and diVerentia-
tion respectively (Budillon et al. 1995, Miller et al.
1996, Saldise et al. 1996). AM and AM-R
expression during the multiple stages of mouse
mammary gland development may reflect a duality
in growth function, whereby proliferative modes of
action are required for elongation or branching of
the glands while a growth suppressive status would
accompany cellular diVerentiation during lactation.
Such possibilities of AM-mediated growth control
in the breast ductal epithelium open several
complex issues, for example: 1) What factor/factors
regulate AM/AM-R expression? 2) Does AM/
AM-R regulation manifest at the transcriptional or
translational level? 3) Is there a hormone depen-
dency to the growth control mechanism? The
answers to some or all of these questions will
require additional investigative studies beyond the
scope of this paper.
The frequent nuclear staining for AM found in
our study is diYcult to interpret but suggests an
involvement of AM in the biological events taking
place in the nuclear compartment. The fact that
some but not all of the cells of a given ductal section
show their nuclei stained suggests diVerences
between the biological traits of diVerent populations
of ductal epithelial cells. Silberstein et al. (1996),
have recently reported the same type of diVerences
in the nuclear/cytoplasmic immunolocalization of
progesterone receptors in the developing mouse
mammary gland. Their work supports the hypoth-
esis that at least two cell types, with diVerent
responsiveness to progesterone receptor, are present
in the ductal epithelium.
Immunoreactive AM has been previously ident-
ified in several luminal epithelia including that of
the bronchii (Martı´nez et al. 1995a) and vaginal
tract (Jahnke et al. 1996). The peptide appears to
concentrate apically along cell borders and is
thought to be released into the luminal space
(Martı´nez et al. 1995a), similar to that observed for
the magainins and tracheal antimicrobial peptide
(ZasloV 1987, Diamond et al. 1991). We have
identified comparable staining characteristics for
AM in ductal epithelium of the mouse mammary
gland, suggesting the possibility that AM may play
a role in the maternal host defense mechanism.
Interestingly, we have identified fully processed
AM in the milk extracts from lactating mice.
Transfer of the mature peptide to the neonate may
provide a nutritional/developmental role for the
peptide in neonatal maturation, similar to what has
been shown for EGF. In the lactating mammary
gland, EGF is processed from a transmembrane
precursor form. The presence of EGF in the milk
is essential for the development of the neonatal
gastrointestinal tract (Koldovsky et al. 1993).
In conclusion, we have identified AM and AM-R
expression in mouse mammary glands using a
variety of experimental techniques. AM and AM-R
were present in all stages of breast development
and were neither aVected by the lack of ovarian
hormones, nor their presence in the ovariectomized
animal. Characterization of the AM protein by
Western blot analysis demonstrated immunoreac-
tivity corresponding in size to the AM prohormone
and processed intermediate form present in all
developmental stages tested. In addition, the fully
processed form was identified in acid extracts of
mouse milk. AM-R expression was found in the
mammary epithelium and fibroblasts of all develop-
mental stages examined. The localization of both
AM ligand and receptor to ductal epithelial cells
and AM-R without the ligand to the periductal and
fat pad fibroblasts suggests possible autocrine
figure 5. Western blot with antibody to AM of mouse
milk extract under reducing and non-reducing
conditions (A) and with antibody preabsorbed to
synthetic P072 peptide (B).
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and paracrine involvement respectively. Further
investigations are necessary to determine the
involvement of AM and AM-R in ductal homeo-
stasis, growth regulation, pathogen protection, and
nutritional supplementation to the neonate.
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